Plain-spoken notes on the compounds we supply — what the literature shows, how to read a COA, and the protocols that protect your data. Cited, never hyped.
Regulation
Is NMN legal in Europe? It is classified as a Novel Food — and as of 2026 still unauthorised, with EFSA opinions in and…
Regulation
The 2026 list names dozens of growth-hormone peptides as prohibited at all times for athletes. But the silences in Section S2 — BPC-157, TB-500,…
Regulation
RUO is a labelling category about intended use, not a quality grade or a safety claim. It is legitimate for genuine laboratory science —…
Regulation
A research peptide sold across Europe, never approved as a medicine, and quietly governed by the question almost nobody asks correctly.
Regulation
A neutral 2026 map of how the FDA, the EMA and the anti-doping world actually treat research peptides — and why “Research Use Only”…
Regulation
On 1 June 2026 the European Medicines Agency published its first rulebook for manufacturing synthetic-peptide medicines. Here is what it actually says, what it…
Regulation
A US advisory committee meets on 23–24 July 2026 to weigh whether a group of research peptides — including BPC-157 and TB-500 — should…
Occasional, considered notes on the compounds and the literature. No noise.
Subscribe & earn 500 pointsCookies
We use strictly necessary cookies to run the store. With your consent we also use analytics (order attribution) and marketing (Omnisend) cookies. Read our Cookie Policy.
